Inhibition of tumorigenesis in ApcMin/+ mice by a combination of (-)-epigallocatechin-3-gallate and fish oil

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 19, 2007, Pages 7695-7700

  Bose, Mousumi ^a   Hao, Xingpei ^a   Ju, Jihyeung ^a   Husain, Ali ^a   Park, Sunny ^a   Lambert, Joshua D ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

( ) Epigallocatechin gallate; ApcMin + mouse; Fish oil; Intestinal cancer

Indexed keywords

MUS;

ANTINEOPLASTIC AGENT; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; FISH OIL;

ANIMAL; ARTICLE; C57BL MOUSE; COLON POLYPOSIS; FAT INTAKE; FEMALE; GENETICS; INTESTINE TUMOR; MALE; MOUSE; MUTATION; TRANSGENIC MOUSE;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; ANTICARCINOGENIC AGENTS; CATECHIN; DIETARY FATS; FEMALE; FISH OILS; GERM-LINE MUTATION; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 34948844451     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf071004r     Document Type: Article

References (42)

1. Cancer Facts and Figures 2007. http://www.cancer.org/downloads/STT/ CAFF2007PWSecured.pdf (April 15, 2007).
2. Kono, S.; Shinchi, K.; Ikeda, N.; Yanai, F.; Imanishi, K. Physical activity, dietary habits and adenomatous polyps of the sigmoid colon: A study of self-defense officials in Japan. J. Clin. Epidemiol. 1991, 44, 1255-1261.
3. Tavani, A.; Franceschi, S.; Levi, F.; La Vecchia, C. Fish, omega-3 polyunsaturated fat intake and cancer at selected sites. World Rev. Nutr. Diet 2005, 94, 166-175.
4. Yang, C. S.; Maliakal, P.; Meng, X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 25-54.
5. Lambert, J. D.; Hong, J.; Yang, G. Y.; Liao, J.; Yang, C. S. Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations. Am. J. Clin. Nutr. 2005, 81, 284S-291S.
6. Higdon, J. V.; Frei, B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 2003, 43, 89-143.
7. Orner, G. A.; Dashwood, W. M.; Blum, C. A.; Diaz, G. D.; Li, Q.; Al-Fageeh, M.; Tebbutt, N.; Heath, J. K.; Ernst, M.; Dashwood, R. H. Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mutat. Res. 2002, 506-507, 121-127.
8. Ju, J.; Liu, Y.; Hong, J.; Huang, M. T.; Conney, A. H.; Yang, C. S. Effects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse model. Nutr. Cancer 2003, 46, 172-178.
9. Ju, J.; Hong, J.; Zhou, J. N.; Pan, Z.; Bose, M.; Liao, J.; Yang, G. Y.; Liu, Y. Y.; Hou, Z.; Lin, Y.; Ma, J.; Shih, W. J.; Carothers, A. M.; Yang, C. S. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)- epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 2005, 65, 10623-10631.
10. Clapper, M. L.; Coudry, J.; Chang, W. C. Beta-catenin-mediated signaling: a molecular target for early chemopreventive intervention. Mutat. Res. 2004, 555, 97-105.
11. Kato, T.; Hancock, R. L.; Mohammadpour, H.; McGregor, B.; Manalo, P.; Khaiboullina, S.; Hall, M. R.; Pardini, L.; Pardini, R. S. Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett. 2002, 187, 169-177.
12. Rao, C. V.; Hirose, Y.; Indranie, C.; Reddy, B. S. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res. 2001, 61, 1927-1933.
13. Reddy, B. S. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention. Environ. Mol. Mutagen. 2004, 44, 26-35.
14. Paulsen, J. E.; Elvsaas, I. K.; Steffensen, I. L.; Alexander, J. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis 1997, 18, 1905-1910.
15. Calviello, G.; Di Nicuolo, F.; Gragnoli, S.; Piccioni, E.; Serini, S.; Maggiano, N.; Tringali, G.; Navarra, P.; Ranelletti, F. O.; Palozza, P. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 2004, 25, 2303-2310.
16. Schwartz, B.; Birk, Y.; Raz, A.; Madar, Z. Nutritional-pharmacological combinations - A novel approach to reducing colon cancer incidence. Eur. J. Nutr. 2004, 43, 221-229.
17. Orner, G. A.; Dashwood, W. M.; Blum, C. A.; Diaz, G. D.; Li, Q.; Dashwood, R. H. Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 2003, 24, 263-267.
18. Serrano, D.; Lazzeroni, M.; Decensi, A. Chemoprevention of colorectal cancer: An update. Technol. Coloproctol. 2004, 8 (Suppl. 2), s248-s252.
19. Bresalier, R. S.; Sandler, R. S.; Quan, H.; Bolognese, J. A.; Oxenius, B.; Horgan, K.; Lines, C.; Riddell, R.; Morton, D.; Lanas, A.; Konstant, M. A.; Baron, J. A. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med. 2005, 352, 1092-1102.
20. Solomon, S. D.; McMurray, J. J.; Pfeffer, M. A.; Wittes, J.; Fowler, R.; Finn, P.; Anderson, W. F.; Zauber, A.; Hawk, E.; Bertagnolli, M. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med. 2005, 352, 1071-1080.
21. Ireson, C. R.; Jones, D. J.; Orr, S.; Coughtrie, M. W.; Boocock, D. J.; Williams, M. L.; Farmer, P. B.; Steward, W. P.; Gescher, A. J. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 105-111.
22. Lambert, J. D.; Yang, C. S. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat. Res. 2003, 523-524, 201-208.
23. Lambert, J. D.; Hong, J.; Kim, D. H.; Mishin, V. M.; Yang, C. S. Pipeline enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3- gallate in mice. J. Nutr. 2004, 134, 1948-1952.
24. Sporn, M. B.; Suh, N. Chemoprevention of cancer. Carcinogenesis 2000, 21, 525-530.
25. Jalving, M.; Koornstra, J. J.; De Jong, S.; De Vries, E. G.; Kleibeuker, J. H. Review article: The potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol. Ther. 2005, 21, 321-339.
26. Moser, A. R.; Dove, W. F.; Roth, K. A.; Gordon, J. I. The Min (multiple intestinal neoplasia) mutation: Its effect on gut epithelial cell differentiation and interaction with a modifier system. J. Cell. Biol. 1992, 116, 1517-1526.
27. Omega Protein, I. Virginia Prime Silver Menhaden Oil Typical Fatty Acid Composition, http://www.omegaproteininc.com/pdf/VPs-spec.pdf (July 2, 2007).
28. Yang, K.; Fan, K.; Newmark, H.; Leung, D.; Lipkin, M.; Steele, V. E.; Kelloff, G. J. Cytokeratin, lectin, and acidic mucin modulation in differentiating colonic epithelial cells of mice after feeding Western-style diets. Cancer Res. 1996, 56, 4644-4648.
29. Hao, X. P.; Pretlow, T. G.; Rao, J. S.; Pretlow, T. P. Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res. 2001, 61, 8085-8088.
30. Lowry, R. VassarStats: Statistical Computation Website, http://faculty.vassar.edu/lowry/VassarStats.html (March 31, 2006).
31. Schneider, K.; Oltmanns, J.; Hassauer, M. Allometric principles for interspecies extrapolation in toxicological risk assessment-empirical investigations. Regul. Toxicol. Pharmacol. 2004, 39, 334-347.
32. Subcommitee on Laboratory Animal Nutrition, C. o. A. N., Board on Agriculture, National Research Council. Nutrient Requirements of Laboratory Animals, 4th revised ed.; National Academies Press: Washington, DC, 1995.
33. Petrik, M. B.; McEntee, M. F.; Chiu, C. H.; Whelan, J. Antagonism of arachidonic acid is linked to the antitumorigenic effect of dietary eicosapentaenoic acid in Apc(Min/+) mice. J. Nutr. 2000, 130, 1153-1158.
34. Petrik, M. B.; McEntee, M. F.; Johnson, B. T.; Obukowicz, M. G.; Whelan, J. Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice. J. Nutr. 2000, 130, 2434-2443.
35. Schley, P. D.; Jijon, H. B.; Robinson, L. E.; Field, C. J. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 2005, 92, 187-195.
36. Peng, G.; Dixon, D. A.; Muga, S. J.; Smith, T. J.; Wargovich, M. J. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol. Carcinog. 2006, 45, 309-319.
37. Shimizu, M.; Deguchi, A.; Lim, J. T.; Moriwaki, H.; Kopelovich, L.; Weinstein, I. B. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin. Cancer Res. 2005, 11, 2735-2746.
38. Moran, A. E.; Hunt, D. H.; Javid, S. H.; Redston, M.; Carothers, A. M.; Bertagnolli, M. M. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice. J. Biol. Chem. 2004, 279, 43261-43272.
39. Shimizu, M.; Deguchi, A.; Joe, A. K.; McKoy, J. F.; Moriwaki, H.; Weinstein, I. B. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J. Exp. Ther. Oncol. 2005, 5, 69-78.
40. Sah, J. F.; Balasubramanian, S.; Eckert, R. L.; Rorke, E. A. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem. 2004, 279, 12755-12762.
41. Datta, S. R.; Dudek, H.; Tao, X.; Masters, S.; Fu, H.; Gotoh, Y.; Greenberg, M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91, 231-241.
42. Cardone, M. H.; Roy, N.; Stennicke, H. R.; Salvesen, G. S.; Franke, T. F.; Stanbridge, E.; Frisch, S.; Reed, J. C. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998, 282, 1318-1321.